Literature DB >> 29654809

Pituitary adenylate cyclase-activating polypeptide is a potent broad-spectrum antimicrobial peptide: Structure-activity relationships.

Charles G Starr1, Jerome L Maderdrut2, Jing He1, David H Coy2, William C Wimley3.   

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) is a naturally occurring cationic peptide with potent immunosuppressant and cytoprotective activities. We now show that full length PACAP38 and to a lesser extent, the truncated form PACAP27, and the closely related vasoactive intestinal peptide (VIP) and secretin had antimicrobial activity against the Gram-negative bacteria Escherichia coli in the radial diffusion assay. PACAP38 was more potent than either the bovine neutrophil antimicrobial peptide indolicidin or the synthetic antimicrobial peptide ARVA against E. coli. PACAP38 also had activity against the Gram-positive bacteria Staphylococcus aureus in the same assay with comparable potency to indolicidin and ARVA. In the more stringent broth dilution assay, PACAP38 had moderate sterilizing activity against E. coli, and potent sterilizing activity against the Gram-negative bacteria Pseudomonas aeruginosa. PACAP27, VIP and secretin were much less active than PACAP38 in this assay. PACAP38 also had some activity against the Gram-positive bacteria Bacillus cereus in the broth dilution assay. Many exopeptidase-resistant analogs of PACAP38, including both receptor agonists and antagonists, had antimicrobial activities equal to, or better than PACAP38, in both assays. PACAP38 made the membranes of E. coli permeable to SYTOX Green, suggesting a classical membrane lytic mechanism. These data suggest that analogs of PACPAP38 with a wide range of useful biological activities can be made by judicious substitutions in the sequence.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Antimicrobial peptides; Innate immunity; Pituitary adenylate cyclase-activating polypeptide; Vasoactive intestinal peptide

Mesh:

Substances:

Year:  2018        PMID: 29654809      PMCID: PMC5982112          DOI: 10.1016/j.peptides.2018.04.006

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  58 in total

1.  High-throughput discovery of broad-spectrum peptide antibiotics.

Authors:  Ramesh Rathinakumar; William C Wimley
Journal:  FASEB J       Date:  2010-04-21       Impact factor: 5.191

2.  Pulmonary and systemic effects of inhaled PACAP38 in healthy male subjects.

Authors:  D Doberer; M Gschwandtner; W Mosgoeller; C Bieglmayer; H Heinzl; V Petkov
Journal:  Eur J Clin Invest       Date:  2007-08       Impact factor: 4.686

3.  Elucidation of vasoactive intestinal peptide pharmacophore for VPAC(1) receptors in human, rat, and guinea pig.

Authors:  Hisato Igarashi; Tetsuhide Ito; Wei Hou; Samuel A Mantey; Tapas K Pradhan; Charles D Ulrich; Simon J Hocart; David H Coy; Robert T Jensen
Journal:  J Pharmacol Exp Ther       Date:  2002-04       Impact factor: 4.030

Review 4.  Insights into the structure of class B GPCRs.

Authors:  Kaspar Hollenstein; Chris de Graaf; Andrea Bortolato; Ming-Wei Wang; Fiona H Marshall; Raymond C Stevens
Journal:  Trends Pharmacol Sci       Date:  2013-12-18       Impact factor: 14.819

5.  Host Cell Interactions Are a Significant Barrier to the Clinical Utility of Peptide Antibiotics.

Authors:  Charles G Starr; Jing He; William C Wimley
Journal:  ACS Chem Biol       Date:  2016-11-07       Impact factor: 5.100

6.  Immunolocalization of muscarinic and VIP receptor subtypes and their role in stimulating goblet cell secretion.

Authors:  J D Ríos; D Zoukhri; I M Rawe; R R Hodges; J D Zieske; D A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-05       Impact factor: 4.799

7.  The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers.

Authors:  Steffen Birk; John Thomas Sitarz; Kenneth Ahrend Petersen; Peter Sandor Oturai; Christina Kruuse; Jan Fahrenkrug; Jes Olesen
Journal:  Regul Pept       Date:  2007-01-03

Review 8.  CFTR, mucins, and mucus obstruction in cystic fibrosis.

Authors:  Silvia M Kreda; C William Davis; Mary Callaghan Rose
Journal:  Cold Spring Harb Perspect Med       Date:  2012-09-01       Impact factor: 6.915

9.  Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier.

Authors:  W A Banks; A J Kastin; G Komaki; A Arimura
Journal:  J Pharmacol Exp Ther       Date:  1993-11       Impact factor: 4.030

Review 10.  Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections.

Authors:  Craig Winstanley; Siobhan O'Brien; Michael A Brockhurst
Journal:  Trends Microbiol       Date:  2016-03-03       Impact factor: 17.079

View more
  13 in total

1.  An ancient neuropeptide defends the brain against infection.

Authors:  Michael Zasloff
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

2.  PACAP is a pathogen-inducible resident antimicrobial neuropeptide affording rapid and contextual molecular host defense of the brain.

Authors:  Ernest Y Lee; Liana C Chan; Huiyuan Wang; Juelline Lieng; Mandy Hung; Yashes Srinivasan; Jennifer Wang; James A Waschek; Andrew L Ferguson; Kuo-Fen Lee; Nannette Y Yount; Michael R Yeaman; Gerard C L Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-05       Impact factor: 11.205

Review 3.  The antimicrobial peptides and their potential clinical applications.

Authors:  Jun Lei; Lichun Sun; Siyu Huang; Chenhong Zhu; Ping Li; Jun He; Vienna Mackey; David H Coy; Quanyong He
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 4.  Application of Synthetic Molecular Evolution to the Discovery of Antimicrobial Peptides.

Authors:  William C Wimley
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

5.  A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer Patients.

Authors:  Oiana Telleria; Oihane E Alboniga; Marc Clos-Garcia; Beatriz Nafría-Jimenez; Joaquin Cubiella; Luis Bujanda; Juan Manuel Falcón-Pérez
Journal:  Metabolites       Date:  2022-06-15

6.  PACAP Is Lethal to Flavobacterium psychrophilum Through Either Direct Membrane Permeabilization or Indirectly, by Priming the Immune Response in Rainbow Trout Macrophages.

Authors:  Shawna L Semple; Tania Rodríguez-Ramos; Yamila Carpio; John S Lumsden; Mario P Estrada; Brian Dixon
Journal:  Front Immunol       Date:  2019-04-26       Impact factor: 7.561

7.  Pituitary Adenylate Cyclase-Activating Polypeptide-A Neuropeptide as Novel Treatment Option for Subacute Ileitis in Mice Harboring a Human Gut Microbiota.

Authors:  Stefan Bereswill; Ulrike Escher; Anne Grunau; Anja A Kühl; Ildiko R Dunay; Andrea Tamas; Dora Reglodi; Markus M Heimesaat
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

8.  Induction of Chicken Host Defense Peptides within Disease-Resistant and -Susceptible Lines.

Authors:  Hyun-Jun Jang; Melissa Monson; Michael Kaiser; Susan J Lamont
Journal:  Genes (Basel)       Date:  2020-10-14       Impact factor: 4.096

9.  NoPv1: a synthetic antimicrobial peptide aptamer targeting the causal agents of grapevine downy mildew and potato late blight.

Authors:  Monica Colombo; Simona Masiero; Stefano Rosa; Elisabetta Caporali; Silvia Laura Toffolatti; Chiara Mizzotti; Luca Tadini; Fabio Rossi; Sara Pellegrino; Rita Musetti; Riccardo Velasco; Michele Perazzolli; Silvia Vezzulli; Paolo Pesaresi
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

10.  Identification and Rational Design of a Novel Antibacterial Peptide Dermaseptin-AC from the Skin Secretion of the Red-Eyed Tree Frog Agalychnis callidryas.

Authors:  Zijian Gong; Xinjie Pei; Shen Ren; Xiaoling Chen; Lei Wang; Chengbang Ma; Xinping Xi; Tianbao Chen; Chris Shaw; Mei Zhou
Journal:  Antibiotics (Basel)       Date:  2020-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.